Avelox and Malignant neoplasm progression - a phase IV clinical study of FDA data
Summary:
Malignant neoplasm progression is reported as a side effect among people who take Avelox (moxifloxacin hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Zometa, and have Metastases to bone.
The phase IV clinical study analyzes which people have Malignant neoplasm progression when taking Avelox. It is created by eHealthMe based on reports of 27,890 people who have side effects when taking Avelox from the FDA, and is updated regularly.
What is Avelox?
Avelox has active ingredients of moxifloxacin hydrochloride. It is often used in sinusitis. eHealthMe is studying from 28,651 Avelox users. Check the latest studies of Avelox.
What is Malignant neoplasm progression?
Malignant neoplasm progression (cancer tumour came back) is found to be associated with 1,508 drugs and 1,637 conditions by eHealthMe. Check the latest studies of Malignant neoplasm progression.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
27,890 people reported to have side effects when taking Avelox.
Among them, 107 people (0.38%) have Malignant neoplasm progression.
Among these 107 people:
How long have people been on Avelox when they have Malignant neoplasm progression? *
What is the gender of people who have Malignant neoplasm progression when taking Avelox? *
What is the age of people who have Malignant neoplasm progression when taking Avelox? *
What are other drugs people take besides Avelox? *
What are other side effects people have besides Malignant neoplasm progression? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Avelox and have Malignant neoplasm progression?
- Check whether Malignant neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Avelox:
- Avelox (28,651 reports)
Malignant neoplasm progression treatments and more:
- Malignant neoplasm progression (107,528 reports)
How severe was Malignant neoplasm progression and when was it recovered:
Expand to all the drugs that have ingredients of moxifloxacin hydrochloride:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Avelox:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Malignant neoplasm progression:
- Malignant neoplasm progression (1,508 drugs)
Browse all the conditions that are associated with Malignant neoplasm progression:
- Malignant neoplasm progression (1,637 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on moxifloxacin hydrochloride (the active ingredients of Avelox) and Avelox (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Mobic cause Abnormal Faeces? - now
- Could Wellbutrin cause Tonsillitis? - 2 seconds ago
- Ulcerative Colitis and Flushing Aggravated - 3 seconds ago
- Could Revlimid cause Emotional Distress? - 4 seconds ago
- Could Yaz cause Bradycardia? - 5 seconds ago
- Could Revlimid cause Epigastric Discomfort? - 10 seconds ago
- Coreg Cr vs. Timolol Maleate, side effect and effectiveness comparison - 15 seconds ago
- Drug interactions of Fish Oil and Zyrtec - 16 seconds ago
- Trigeminal Neuralgia and Pruritus Generalised - 19 seconds ago
- Could Wellbutrin Xl cause Mania Aggravated? - 21 seconds ago